Medical & regulatory disclaimer
In short: nothing here is medical advice or promotion of a medicine. To report a side effect in India, call the PvPI helpline 1800-180-3024 (toll-free). In an emergency, call 112.
- Not medical advice
- No promotion of medicines to the public
- Information for healthcare professionals
- Reporting a side effect (adverse event)
- Standards we work to
- Use of AI tools
- Accuracy and links
- Trademarks
Not medical advice
Information on this website is general and educational and is provided to describe our services. It is not a substitute for advice from a qualified healthcare professional. Do not use it to diagnose or treat any condition. In a medical emergency in India call 112, or your local emergency number.
No promotion of medicines to the public
This website does not promote any prescription medicine to the public. It is written to respect:
- the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945, including the limits on advertising Schedule H, H1 and X medicines;
- the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954;
- the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024.
Samples on this website use generic molecule names and published data only to demonstrate our work. They have not been reviewed or approved by any marketing authorisation holder and must not be used as prescribing information.
Information for healthcare professionals
Clinical figures shown in samples are cited to their published sources and were accurate to the best of our knowledge on the date shown. Approved indications, doses and safety information differ between countries. Always refer to the current locally approved prescribing information.
Reporting a side effect (adverse event)
Please do not report side effects through this website or by email to us. Instead:
- India: contact the company that markets the medicine, or the Pharmacovigilance Programme of India (PvPI) on the toll-free helpline 1800-180-3024, or through the ADR PvPI mobile app.
- United States: FDA MedWatch (fda.gov/medwatch) or 1-800-FDA-1088.
- United Kingdom: the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
- European Union: your national medicines authority, listed by the European Medicines Agency.
- Elsewhere: your national medicines regulator or the company that markets the medicine.
If we receive adverse event information by mistake, we will pass it to the relevant marketing authorisation holder where we can identify one, as our client agreements require, and will not otherwise use it.
Standards we work to
We create client materials to support compliance with UCPMP 2024 and Indian law, and, for international work, the IFPMA Code of Practice, the EFPIA and ABPI Codes, the PhRMA Code and US FDA (OPDP) expectations, together with each client’s own medical, legal and regulatory (MLR) review. Final approval of any material is always the client’s responsibility.
Use of AI tools
Where we use AI tools in our work, a qualified person reviews every output, claims are checked against their sources, and we do not put client confidential or personal data into public AI services.
Accuracy and links
We review content regularly but cannot guarantee it is complete or current at all times. Links to external sites are for convenience; we are not responsible for their content.
Trademarks
Product names and trademarks belong to their respective owners.